The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2001-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1359/jbmr.2001.16.2.398PMID 11204440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidemiology of fragility fractures: Is there a role for bone quality?

  2005cited by this paper
• Bone quality: A determinant for certain risk factors for bone fragility

  2005cited by this paper
• Growth Hormone, Insulin-like Growth Factors

  2001cited by this paper
• CHAPTER 79 – Growth Hormone and Insulin-Like Growth Factors: Potential Applications and Limitations in the Management of Osteoporosis

  2001cited by this paper
• Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group.

  1999cited by this paper
• Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency.

  1999cited by this paper
• The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.

  1999cited by this paper
• GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

  1999cited by this paper
• Growth Hormone Replacement Therapy Is Not Associated with Any Increase in Mortality

  1999cited by this paper
• Growth hormone and bone.

  1998cited by this paper
• Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

  1998cited by this paper
• Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis.

  1998cited by this paper
• Changes in the fracture toughness of bone may not be reflected in its mineral density, porosity, and tensile properties.

  1998cited by this paper
• Epidemiology of Medication-Related Falls and Fractures in the Elderly

  1998cited by this paper
• A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update

  1998cited by this paper
• Long‐term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long‐term GH replacement therapy

  1998cited by this paper
• [Epidemiology of osteoporosis].

  1998cited by this paper
• Effect of long‐term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH‐deficient adults

  1998cited by this paper
• Bone Mineral, Histomorphometry, and Body Composition in Adults with Growth Hormone Receptor Deficiency

  1998cited by this paper
• Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

  1998cited by this paper
• Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.

  1997cited by this paper
• The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men.

  1997cited by this paper
• Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone Deficiency

  1996cited by this paper
• Fall-related factors and risk of hip fracture: the EPIDOS prospective study.

  1996cited by this paper
• Influence of body composition on bone mineral content in children and adolescents.

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

  1996cited by this paper
• Drug-induced metabolic bone disease.

  1995cited by this paper
• Reduced bone mineral density in patients with adult onset growth hormone deficiency.

  1994cited by this paper
• Consequences of childhood‐onset growth hormone deficiency for adult bone mass

  1994cited by this paper
• Growth hormone and bone metabolism.

  1993cited by this paper
• Short and long‐term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone‐deficient males *

  1993cited by this paper
• Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3

  1993cited by this paper
• Bone mass measurement: prediction of risk.

  1993cited by this paper
• Long‐term fracture prediction by bone mineral assessed at different skeletal sites

  1993cited by this paper
• Reduced bone mineral content in adult patients with growth hormone deficiency.

  1993cited by this paper
• Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.

  1992cited by this paper
• The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin‐like growth factor I

  1992cited by this paper
• The relationship of bone mineral density and anthropometric variables in healthy male and female children.

  1991cited by this paper
• Osteoporosis in Men: Diagnosis, Pathophysiology, and Prevention

  1990cited by this paper
• Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters.

  1990cited by this paper
• Impaired Vision and Hip Fracture

  1989cited by this paper
• Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.

  1984cited by this paper

• Potential impacts of adult growth hormone deficiency: a population-based study in England

  2026cites this paper
• Growth hormone and bone: pre-clinical and clinical perspectives.

  2025cites this paper
• Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study

  2025cites this paper
• Growth hormone replacement therapy in childhood-onset craniopharyngioma.

  2025cites this paper
• Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study

  2025cites this paper
• Deficiency of arginine vasopressin in children – diagnostic and therapeutic approaches to improve patients' quality of life based on a 25-year, single-centre retrospective analysis

  2024cites this paper
• Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)

  2024cites this paper
• Endocrine health in survivors of adult-onset cancer.

  2024cites this paper
• Bone Quality Indices Correlate with Growth Hormone Secretory Capacity in Women Affected by Weight Excess: A Cross-Sectional Study

  2024cites this paper
• Accuracy of Glucagon Testing Across Transition in Young Adults With Childhood-Onset GH Deficiency

  2024cites this paper
• Diagnosis and therapeutic approach to bone health in patients with hypopituitarism

  2024influential citation
• Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality

  2024influential citation
• Skeletal fragility in pituitary disease: how can we predict fracture risk?

  2024cites this paper
• Short Stature in children: Review Article

  2023cites this paper
• Differences between bone health parameters in adults with acromegaly and growth hormone deficiency: A systematic review.

  2023cites this paper
• The influence of growth hormone deficiency on bone health and metabolisms

  2023cites this paper
• Bone quality in endocrine diseases: determinants and clinical relevance

  2023cites this paper
• Impact of GH administration on skeletal endpoints in adults with overweight/obesity.

  2022cites this paper
• Musculoskeletal Effects of Altered GH Action

  2022cites this paper
• Skeletal disorders associated with the growth hormone–insulin-like growth factor 1 axis

  2022cites this paper
• Growth hormone deficiency in adults with hypopituitarism—What are the risks and can they be eliminated by therapy?

  2021cites this paper
• Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment

  2021cites this paper
• Induction of somatopause in adult mice compromises bone morphology and exacerbates bone loss during aging

  2021cites this paper
• Update on vertebral fractures in pituitary diseases: from research to clinical practice

  2021cites this paper
• Growth hormone deficiency in adults with Cushing's disease.

  2020cites this paper
• Effect of complex therapy of medulloblastoma in childhood and adolescence on bone mineral density

  2020cites this paper
• Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men

  2020cites this paper
• Growth hormone, insulin-like growth factors, and IGF binding proteins

  2020cites this paper
• Introductory Chapter: Growth Disorders

  2020cites this paper
• Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature

  2020cites this paper
• Deficits in Bone Geometry in Growth Hormone-Deficient Prepubertal Boys Revealed by High-Resolution Peripheral Quantitative Computed Tomography

  2020cites this paper
• Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years

  2020cites this paper
• Somatotropic Axis in Human Aging

  2019cites this paper
• Growth Hormone Deficiency Following Traumatic Brain Injury

  2019cites this paper
• Significance of visceral adipose index on evaluating insulin resistance in Chinese adult patients with growth hormone deficiency

  2019cites this paper
• Muscle Strength Training is Better than the Use of Growth Hormone (GH) in Bone Health of Wistar Rats

  2019cites this paper
• Secondary Osteoporosis

  2019cites this paper
• Physiopathology, Diagnosis, and Treatment of GH Deficiency

  2018cites this paper
• Pituitary Diseases and Bone

  2018cites this paper
• GH/IGF-I and Bone

  2018cites this paper
• Childhood-onset growth hormone deficiency and the transition to adulthood: current perspective

  2018cites this paper
• Effects on bone health of glucocorticoid replacement therapy in primary and secondary adrenal insufficiency: A review

  2018cites this paper
• Neuroendocrinology of Bone Metabolism

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 2

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 1

  2018cites this paper
• Comorbidities in patients with non-functioning pituitary adenoma : influence of long-term growth hormone replacement

  2018cites this paper
• Cortical porosity, medullary adiposity, type 2 diabetes mellitus, serum vitamin D, parathyroid hormone, and nonvertebral fractures

  2018cites this paper
• Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 2

  2018cites this paper
• Hypothalamic-Pituitary Diseases

  2018cites this paper
• Der Effekt von Wachstumshormon auf die menschlichen Alterungsprozesse. Teil 1

  2018cites this paper
• Insulin-like growth factors: actions on the skeleton.

  2018cites this paper
• Multidisciplinary Approach to Osteoporosis

  2018cites this paper
• Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review.

  2018cites this paper
• [Issues related to secondary osteoporosis associated with growth hormone deficiency in adulthood].

  2018cites this paper
• Growth hormone deficiency and replacement effect on adult bone mass: A clinical update

  2018cites this paper
• Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis

  2017cites this paper
• Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein

  2017cites this paper
• Bone health and body composition of children and adolescents with growth hormone deficiency

  2017cites this paper
• Focus on growth hormone deficiency and bone in adults.

  2017cites this paper
• Negative Association of Plasma Cholesterol and Low-density Lipoprotein Cholesterol, but not Testosterone or Growth Hormone, with Bone Mineral Density in Elderly Korean Men

  2016cites this paper
• Skeletal health in adult growth hormone deficiency

  2016cites this paper
• Endocrine Consequences: Diagnostic Workout and Treatment

  2016cites this paper
• The interaction between growth hormone and the thyroid axis in hypopituitary patients: in vivo and ex vivo studies

  2016cites this paper
• Short Anabolic Peptides for Bone Growth

  2016cites this paper
• Effects of Growth Hormone on Bone.

  2016cites this paper
• Chapter 11 – Hypopituitarism and Growth Hormone Deficiency

  2016cites this paper
• Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency

  2016cites this paper
• Trabecular bone score as a skeletal fragility index in acromegaly patients

  2016cites this paper
• Bone Mineral Density in Sheehan's Syndrome; Prevalence of Low Bone Mass and Associated Factors.

  2016cites this paper
• Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study.

  2016cites this paper
• Growth hormone receptor isoforms and fracture risk in adult‐onset growth hormone‐deficient patients

  2016cites this paper
• Acromegalic osteopathy

  2016cites this paper
• Effects of Glucocorticoids on Bone: What we can Learn from Pediatric Endogenous Cushing’s Syndrome

  2016cites this paper
• Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement

  2016cites this paper
• Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults

  2016cites this paper
• Gender-Specific Associations of Serum Insulin-Like Growth Factor-1 With Bone Health and Fractures in Older Persons.

  2015cites this paper
• GH therapy in transition age: state of the art and future perspectives.

  2015cites this paper
• Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study.

  2015cites this paper
• Pituitary diseases and bone.

  2015cites this paper
• Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study.

  2015cites this paper
• Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy

  2015cites this paper
• Osteogenesis imperfecta type III and hypogonadotropic hypogonadism result in severe bone loss: a case report

  2015cites this paper
• Correlation of increased plasma osteoprotegerin and cardiovascular risk factors in patients with adult growth hormone deficiency.

  2015cites this paper
• Osteoporosis in pituitary diseases: lessons for the clinic

  2015cites this paper
• Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity

  2014influential citation
• Mechanisms and effects of growth hormone deficiency (due to subarachnoid haemorrhage and traumatic brain injury) on quality of life and regional body composition, and the influence of hormone replacement

  2014cites this paper
• Rapid decline in bone turnover markers but not bone mineral density in acromegalic patients after transsphenoidal surgery.

  2014cites this paper
• Effects of testosterone and growth hormone on the structural and mechanical properties of bone by micro-MRI in the distal tibia of men with hypopituitarism.

  2014cites this paper
• Secondary osteoporosis: pathophysiology & diagnosis.

  2014cites this paper
• Capítulo 23 – Guía práctica para la evaluación y el tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales

  2014cites this paper
• Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism.

  2014cites this paper
• Nanotopology potentiates growth hormone signalling and osteogenesis of mesenchymal stem cells.

  2014cites this paper
• Best Practice & Research Clinical Endocrinology & Metabolism

  2014cites this paper
• Pituitary Disorders and Osteoporosis

  2014influential citation
• The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.

  2014cites this paper
• Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: growth hormone deficiency.

  2014cites this paper
• Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions.

  2014cites this paper
• Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.

  2014cites this paper
• Could zinc supplementation improve bone status in growth hormone (GH) deficient children?

  2013cites this paper